Bacillus amyloliquefaciens and application thereof in spiramycin degradation
By using Bacillus amyloliquefaciens fermentation broth to biodegrade spiramycin, the problem of low spiramycin removal efficiency in existing technologies has been solved, achieving efficient and safe spiramycin degradation, which is suitable for wastewater and soil remediation.
Patent Information
- Application Number
- CN202411012708.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-26
- Publication Date
- 2024-11-26
AI Technical Summary
Existing wastewater treatment technologies are ineffective in removing spiramycin, leading to environmental pollution and ecosystem imbalance. Existing methods such as physical and chemical methods are costly or cause secondary pollution, while biological methods are less efficient.
A fermentation broth of a strain of Bacillus amyloliquefaciens was used to treat simulated spiramycin production wastewater, achieving efficient removal of spiramycin through biodegradation.
Within six days, the degradation rate of spiramycin at an initial concentration of 525 mg/L reached 92.70%. The degradation products had no antibacterial activity, and the degradation rate was high and safe, making it suitable for wastewater treatment plants and soil remediation.
Smart Images

Figure CN119020194A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of environmental microorganisms, and particularly relates to the application of a strain of Bacillus amyloliquefaciens in efficiently degrading spiramycin. Background Art
[0002] Antibiotics are a new type of environmental pollutant that not only threatens the ecological environment, but also seriously affects human health. Relevant surveys show that my country, as a major antibiotic user, produces about 2.1×10 5 Tons, and are mainly used in the medical and agricultural industries. Antibiotics have a low metabolic rate in humans and livestock, and it is difficult to completely remove antibiotics with existing sewage treatment technology. Antibiotics discharged into the environment cause surface water pollution and then groundwater pollution. Antibiotics in the environment induce the emergence of drug-resistant bacteria, destroy the balance of the ecosystem, and threaten the survival of organisms. Spiramycin (SPI) is one of the common antibiotic contaminants.
[0003] SPI is commonly used to treat human and veterinary infections. Since the ingested antibiotics cannot be completely digested by the body, the residual antibiotics or their metabolites will enter the external environment through excrement and other means. SPI has been detected in soil, groundwater, surface water, and even drinking water. The concentration of SPI in the influent of sewage treatment plants is between 603 and 2588 ng / L, and its concentration in antibiotic production wastewater and membrane concentrates may reach tens of mg / L. Since the secondary treatment of sewage treatment plants cannot effectively remove SPI, it is often detected in the wastewater and sludge of sewage treatment plants. It is reported that the detection concentration of SPI in the Varese sewage treatment plant in Italy is 603 ng / L, the concentration of SPI in Xinjiang lake water can reach 3.99 ng / L, and the detection concentration in lake sediments in the same water area is as high as 7.8 μg / kg.
[0004] SPI is stable in nature and will hardly hydrolyze under natural environmental conditions. Common methods for SPI degradation include physical, chemical and biological methods. The physical method is simple to operate but requires high energy consumption, is costly and has a certain impact on the environment. The chemical method promotes its degradation by adding chemical agents such as oxidants. Although the degradation efficiency is high, the cost is high and secondary pollution may occur. The biological method of degrading SPI by microbial metabolism is slow but low-cost and environmentally friendly. It is currently the most promising method for removing SPI.
[0005] SPI in the environment can destroy the ecological balance and affect the health of humans and animals. Therefore, it is crucial to study a method that can effectively degrade SPI. There are three reports on the degradation of SPI: the degradation ability of a strain of lactic acid Pediococcus P3-4 for spiramycin with an initial concentration of 8 mg / L reached a maximum value of 82.8% on the 5th day, and then the degradation rate decreased slowly (patent number: CN104946559 B); a strain of Enterococcus faecium E9-10 was co-cultured with spiramycin with an initial concentration of 8 mg / L for 5 days, and the degradation rate of spiramycin reached a maximum value of 61.5% (patent number: CN 104946560 B); a strain of Asclerotiorum isolated from acetylspiramycin residue has the ability to degrade acetylspiramycin, but the degradation effect has not been studied. Summary of the invention
[0006] On the one hand, the present invention provides a new strain capable of degrading spiramycin, Bacillus amyloliquefaciens. The strain is deposited in the General Microbiological Center of China National Committee for the Preservation of Microorganisms on June 25, 2024, at No. 3, Yard No. 1, Beichen West Road, Chaoyang District, Beijing, and the deposit number is: CGMCC No. 31076.
[0007] Another aspect of the present invention provides a method for using Bacillus amyloliquefaciens in the degradation of spiramycin.
[0008] The specific technical solutions of the present invention are as follows:
[0009] The fermentation liquid of Bacillus amyloliquefaciens was inoculated into the simulated spiramycin production wastewater and cultured at 25-37°C for 6 days to degrade the spiramycin therein.
[0010] The fermentation liquid preparation method further comprises: inoculating the Bacillus amyloliquefaciens seed culture liquid into the fermentation medium at an inoculation amount of 5% to 15% (preferably 10%) by volume concentration, and culturing at 25 to 37° C. and 150 to 200 rpm until the OD600 is 0.6 to 2.5 (preferably 37° C. and 200 rpm until the OD600 is 2.5); the fermentation medium mass formula is: 2 to 50 g / L maltose, 2 to 50 g / L peptone, the solvent is deionized water, and the pH value is 6.8 to 7.2.
[0011] The slant activation method further comprises: inoculating the Bacillus amyloliquefaciens slant into an activation medium, and culturing at 35-45° C. for 12-72 hours (preferably culturing at 37° C. for 24 hours); the activation medium is a common broth medium, which is composed of 5-20 g / L of peptone, 1-20 g / L of beef extract, 5-20 g / L of sodium chloride, and 20 g / L of agar, the solvent is distilled water, and the pH value is 6.8-7.2.
[0012] The seed expansion culture method further comprises: inoculating the activated culture fluid into the seed expansion culture medium, culturing at 35-45°C, 80-220rpm for 12-72h (preferably 37°C, 200rpm, 12h) to obtain the seed expansion culture fluid, and the seed expansion culture medium is also a common broth culture medium.
[0013] Compared with the prior art, the beneficial effects of the present invention are mainly reflected in:
[0014] The amyloliquefaciens provided by the present invention has a degradation rate of 92.70% for spiramycin with an initial concentration of 525 mg / L within six days; compared with the relevant patents, the initial concentration of spiramycin in the sewage treated by the present invention is higher, and the degradation rate is also higher, indicating that the strain in the present patent has a stronger ability to degrade spiramycin. In addition, the toxicity evaluation test proves that the degradation product of the strain has no antibacterial activity. The strain can not only be used to improve the spiramycin removal efficiency of spiramycin production sewage treatment plants and municipal sewage treatment plants, but also can be used for the bioremediation of water and soil contaminated by spiramycin and its analogs, and has the advantages of high efficiency, wide range, safety, low cost, etc. BRIEF DESCRIPTION OF THE DRAWINGS
[0015] Figure 1 Colony morphology and microscopic examination of screened strains
[0016] (a), (b), (c), (d), (e) are the colony morphologies of SPI-A, SPI-B, SPI-C, SPI-D, and SPI-E; (f), (g),
[0017] (h), (i), (j) are microscopic images of SPI-A, SPI-B, SPI-C, SPI-D, and SPI-E
[0018] Figure 2 Phylogenetic tree of Bacillus amyloliquefaciens strain JBHJDF3
[0019] Figure 3 Degradation kinetics of spiramycin
[0020] Figure 4 Toxicity trend of spiramycin hydrolysis products DETAILED DESCRIPTION
[0021] In order to better illustrate the present invention, the following embodiments are given, but the protection scope of the present invention is not limited thereto.
[0022] The concentration composition of culture medium and simulated sewage ordinary broth culture medium is: peptone 10g / L, beef extract 5g / L, sodium chloride 5g / L, agar 20g / L, the solvent is distilled water, and the pH value is 7.0.
[0023] Solid nutrient agar medium composition: peptone 10g / L, beef extract 3g / L, sodium chloride 5g / L, agar 17g / L, pH value is 7.2.
[0024] Improved sterile basal mineral medium (BMM) composition: 1.6g / LK 2 HPO 4 , 0.4g / LKH 2 PO 4 , 0.2g / LMgSO 4 7H 2 O, 0.025 g / L CaCl 2 ·2H 2 O, 0.0023 g / L FeCl 3 6H 2 O and 0.5 g / L NH 4 NO 3 , pH value is 7.0.
[0025] The fermentation medium of Bacillus amyloliquefaciens consists of 5 g / L maltose, 10 g / L peptone, deionized water as solvent, and a pH value of 7.0.
[0026] All culture media were sterilized at 121°C for 20 min.
[0027] The final simulated wastewater formula was: 525.0 mg / L SPI, 2335 mg / L glucose, 47.6 mg / L NH 4 Cl, 32.5mg / L KH 2 PO 4 , 20mg / LMgSO 4 7H 2 O, 2.5 mg / L CaCl 2 , 0.55mg / LFeSO 4 , pH value is 8.0. Characteristics of the artificial wastewater (mg / L): COD 3500±305, NH 4 + -N 16.02±0.51,PO 4 3- -P 7.41±0.58, pH 4.5, DO 2.32±0.25.
[0028] Example 1 Analysis Method of Spiramycin and Its Degradation Products
[0029] 1) Analysis of spiramycin concentration
[0030] The concentration of spiramycin was determined by HPLC. The sample was centrifuged at 8000 rpm for 10 min and filtered with a 0.45 μm filter membrane. The sample was then dissolved in 10 volumes of methanol and shaken well. After filtration, it was used for HPLC analysis. Stationary phase: octadecylsilane bonded silica gel (5 μm) column for liquid chromatography, 4.6 mm × 250 mm, mobile phase: a 60:40 mixture of acetonitrile and ammonium acetate (0.05 mol / L), flow rate: 1 mL / min. Column temperature: 30 ° C, detector: UV detector, detection wavelength: 232 nm. Under the above conditions, the concentration of spiramycin was linearly related to the peak area of the HPLC graph in the range of 0 to 10 mg / L, and the linear regression equation was y = 33264x + 954574 (R 2 =0.9965).
[0031] 2) Analysis of spiramycin degradation products
[0032] To analyze the degradation products of SPI, SPI-A was inoculated into BMM containing 5 g / L spiramycin and cultured at 37°C, 200 rpm for three days. The degradation products were analyzed by HPLC-(+)ESI-MS. The samples were pretreated in three cycles: first, extracted with dichloromethane to remove inorganic salts and other water-soluble impurities. Then, the organic solvent was removed by nitrogen blowing. Finally, the powder obtained by methane was dissolved and filtered with a 0.45 μm filter membrane to remove protein.
[0033] The separation equipment used was HPLC (SHIMADZU LC-30A) combined with an ion trap mass spectrometer (ABSCIEX6600). The stationary phase was a Kinetex RP C18 column (2.6μm, 50mm×2.1mm), and the mobile phase was a mixture of 0.1% formic acid aqueous solution (A) and 0.1% formic acid methanol solution (B). The mobile phase gradient elution program was as follows: the content of B increased linearly from the initial 10% to 70% within 3min, then maintained at 80% in the next 2min, and finally decreased to 10% within 1min. SPI and its degradation products were monitored at 232nm. MS measurement: positive mode electrospray ionization (ESI) source, capillary voltage 5.5kV, nebulizer temperature 450℃. The mass spectra were collected in the range of 100-1000m / z using full scan mode. The biodegradation products of spiramycin were identified using total ion chromatograph (TIC).
[0034] Example 2 Screening of strains
[0035] Wastewater from the aerobic pool of the sewage treatment plant of Henan Tianfang Pharmaceutical Co., Ltd. was inoculated into a modified basal mineral medium (BMM) with 1g / L spiramycin added and cultured at 200rpm and 30°C for 24h. Then, 10mL of the culture solution was transferred to another bottle of fresh BMM containing spiramycin and cultured under the same conditions. The enrichment operation was repeated 3 times, and the amount of spiramycin added was gradually increased from 1g / L to 10g / L. The enriched culture was evenly spread on a solid nutrient agar plate containing 10g / L spiramycin, and then cultured at 30°C for 24h.
[0036] The strains that grew well on the nutrient agar plate supplemented with 10 g / L SPI could use SPI as the sole carbon and energy source, indicating that they had the potential to degrade SPI. Five strains of different shapes were streaked on solid nutrient agar plates for purification. The pure colonies were stored in a slant solid medium at 4°C for further study. The five strains were named: SPI-A, SPI-B, SPI-C, SPI-D, SPI-E (see Figure 1 The colony morphology and microscopic characteristics of the bacteria are described in the table below.
[0037] Table 1. Phenotypic description of screened strains
[0038]
[0039] Example 3 Degradation Performance Evaluation
[0040] The five strains selected in Example 2 were inoculated into ordinary broth agar medium, cultured at 37°C for 24h to obtain slant culture for later use; the slant seeds were inoculated into ordinary broth culture, cultured at 37°C and 200rpm for 12h to obtain seeds. The seeds were inoculated into the fermentation medium at 10% (v / v), cultured at 37°C and 200rpm until OD600 was about 2.5, and the fermentation liquid was obtained; the fermentation liquid was centrifuged at 8000rpm and 4°C for 10min to collect microbial cells, and then washed twice with 0.85% (w / w) sodium chloride solution. The obtained bacterial cells were inoculated into BMM containing 5g / L spiramycin, cultured at 200rpm and 37°C for 48h, and used to evaluate its spiramycin degradation performance. All experiments were repeated 3 times.
[0041] The SPI degradation rate calculation formula is as follows:
[0042] SPI degradation rate (%) = (5-C X )÷5×100
[0043] 5 and C X represent the initial and final SPI concentrations of biotreated modified BMMs, respectively.
[0044] The results showed that the degradation rates of spiramycin by strains SPI-A, SPI-B, SPI-C, SPI-D and SPI-E were 29.32%, 26.48%, 23.76%, 18.35% and 16.06%, respectively, among which SPI-A had the best effect, with a degradation rate of 29.32% for the initial 5g / L SPI in 48h. The selected strain SPI-A was identified by morphological characteristics and phylogenetic analysis.
[0045] Example 4 strain identification
[0046] Microbial phenotypic information was obtained by observing colonies with the naked eye and bacterial morphology with an optical microscope. Then, phylogenetic analysis was performed based on their 16S rRNA sequences. Clustal W software was used to perform multiple sequence alignment and phylogenetic tree construction on MEGA 6. When constructing the phylogenetic tree, evolutionary distance data was calculated based on Kimura's two-parameter model, and reference sequences were retrieved from Gen Bank. The specific steps are as follows: 1) Extract bacterial DNA by boiling
[0047] Use an inoculation needle to pick up a single colony on the slant or ordinary broth culture plate, inoculate it into a sterilized ordinary broth medium, set the constant temperature shaker temperature to 37℃, the speed to 200rpm, and ferment and culture under this condition for 12h; take the fermentation liquid that has grown to an appropriate concentration and centrifuge it at 3000rpm for 2min at room temperature; discard the supernatant, add 1×TE200μL with pH8.5, and centrifuge it again at 3000rpm for 2min at room temperature; discard the supernatant again, add 100μL of 1×TE with pH8.5, and cook it in a water bath at 100℃ for 10min. After the water bath ends, take it out immediately and place it on ice for 2min, and centrifuge it again at 3000rpm for 2min at room temperature. Pipette 60μL of the centrifuged supernatant into a clean 1.5mL EP tube as a PCR detection template and place it in a 4℃ refrigerator for storage.
[0048] 2) PCR amplification and electrophoresis detection
[0049] PCR amplification was performed using the universal primers 27F (5'-AGAGTTTGATCCTGGCTCAG-3') and 1429R (5'-GGTTACCTTGTTACGACTT-3') of the 16S rRNA sequence. The 20μL PCR detection system contained: 0.5μL of upstream and downstream primers, 0.5μL of extracted DNA template, 8.5μL of sterile ultrapure water, and finally 10μL of 2×Ex Tap enzyme. The operating parameters of the PCR amplification program were as follows: (94℃, 5min)+{(94℃, 30s)+(55℃, 30s)+(72℃, 1min)}×30+(72℃, 7min). The purity of the amplified PCR product was identified by 1% agarose gel electrophoresis. The PCR product was sent to Qingke Biotechnology Co., Ltd. for sequencing. The sequencing results have been uploaded to the Gen Bank database with the number PP733358.
[0050] According to the results of 16S rRNA sequence alignment, SPI-A belongs to Bacillus amyloliquefaciens, and it was renumbered as JBHJDF3 and deposited in the General Microbiological Center of China Microbiological Culture Collection Administration on June 25, 2024. The deposit address is No. 3, No. 1 Beichen West Road, Chaoyang District, Beijing, and the deposit number is: CGMCC No.31076. ClustalW software was used to perform multiple sequence alignment and phylogenetic tree construction on MEGA 6 ( Figure 2 Phylogenetic analysis showed that strain JBHJDF3 was located in a clade consisting of seven strains of Bacillus amyloliquefaciens, and OR574345.1B. Bacillus amyloliquefaciens strain IP32-12 was its closest relative.
[0051] Example 5: Degradation test of spiramycin in simulated sewage
[0052] In order to obtain better spiramycin degradation results, the culture medium formula and culture conditions of strain JBHJDF3 were first optimized. The optimal culture medium formula is peptone 20g / L, yeast extract 5g / L, sucrose 5g / L, and pH 8.0. The optimal culture conditions are liquid volume 10%, optimal rotation speed 200rpm, optimal culture temperature 37℃, and optimal culture time 24h. The bacterial solution obtained under the optimal conditions was centrifuged at 8000rpm and 4℃ for 10min to collect microbial cells, and the obtained SPI-A cells were inoculated with sterilized simulated wastewater and cultured at 200rpm and 37℃ for 144h. During this period, samples were taken every 24h for the analysis of spiramycin and its degradation intermediates. The degradation kinetics of SPI by strain JBHJDF3 follows the first-order model, as shown in the formula:
[0053] LqCy t =-kt+lnC 0
[0054] In the formula, C 0 is the initial concentration of SPI at time 0, C t is the concentration of SPI at time t, k is the degradation rate constant (d -1 ), t is the degradation duration.
[0055] The test found that the SPI degradation curve dropped rapidly in the first 24 hours, and then dropped at a smaller slope within 5 days. The reason for this trend may be that SPI was rapidly degraded by sufficient SPI degrading enzymes in the first stage. Later, these enzymes were inhibited by SPI degradation intermediates, resulting in a decrease in degradation rate. Another reason is that SPI was quickly absorbed by bacterial cells at the beginning of the experiment and then slowly degraded. After 6 days of biological treatment, the SPI degradation rate reached 92.70%, indicating that the screened strains have a good degradation effect on residual antibiotics in sewage.
[0056] Its degradation kinetics can be seen in Figure 3 The degradation kinetic data of the strain are as follows: regression equation: y = -0.1439x + 0.9986; correlation coefficient: R 2 =0.9311; T 1 / 2 :3.4649.
[0057] The HPLC-(+)ESI-MS analysis results show that the m / z results of spiramycin degradation intermediates in the wastewater samples treated with biodegradation are shown in the table below.
[0058] Table 2. Chemical structures and mass-to-charge ratios of SPI and its degradation intermediates
[0059]
[0060]
[0061] The mass-to-charge ratio (m / z), molecular formula and possible chemical structure of SPI and its degradation intermediates (DIs) are listed in the table.
[0062] Example 6 Acute toxicity assessment of spiramycin degradation products
[0063] pass -Multi Jr monitors the acute toxicity of SPI degradation products by measuring the inhibition of bioluminescence of the photobacterium Vibrio fischeri. 0 and L t The luminescence intensity of the wastewater samples before and after treatment is respectively, and the acute toxicity can be expressed by L t / L 0 For evaluation, all bioassays were performed in triplicate.
[0064] The results showed that the change trend of acute toxicity of SPI degradation products was opposite to that of SPI concentration, which was consistent with the logistic curve ( Figure 4 ). In addition, the luminescence intensity values of the wastewater samples collected at 144 h were similar to those of deionized water (Table 3), indicating that the products of SPI degradation after 6 days did not have antibacterial effects.
[0065] Table 3. Luminescence intensity of samples after SPM removal by BMC system biological treatment
[0066]
Claims
1. A strain of Bacillus amyloliquefaciens, which was deposited in the General Microbiology Center of China Microbiological Culture Collection Administration on June 25, 2024, at No. 3, Yard No. 1, Beichen West Road, Chaoyang District, Beijing, and the deposit number is: CGMCC No.31076.
2. Use of the Bacillus amyloliquefaciens described in claim 1 in degrading spiramycin contained in spiramycin production wastewater.
Citation Information
Cited By
Preparation method and application of compound microorganism sodium humate water-soluble fertilizer
CN121990859A
